The immune therapy program will make cutting edge contributions to the field of immune-oncology by uncovering novel findings in basic and translational research, as well as learning from patient responses in clinical trials to improve response rates and quality of life. Our goal is also to develop novel technologies and reagents to remain at the forefront of this field.
Scientist, Senior Scientist, Clinician Scientist
Hirano, Naoto
(Chair)
Brooks, David
Mak, Tak W
McGaha, Tracy
Ohashi, Pamela
Reedijk, Michael
Affiliate Scientist
Sacher, Adrian
Emeritus Scientist
Paige, Christopher
Staff Scientist
Nguyen, Linh
Clinical Champion
Gerbitz, Armin
Saibil, Sam